Evaluation therapy breakthrough bleeding women triphasic oral contraceptive study incidence pattern breakthrough bleeding BTB women first time triphasic oral contraceptive OC hypothesis management BTB persisting cycles new users control group women various OCs months incidence BTB control group new users first months bleeding package early midway package late-package BTB patient monophasic pill similar estrogenic formulation beginning package vice versa early midpackage BTB Seventy women BTB months months bleeding likely women regardless package BTB 